Literature DB >> 25400805

Carcinoid tumor of the middle ear: a case report and review of literature.

Guo Liu1, Fei Chen1, Jin-Nan Li2, Shi-Xi Liu1.   

Abstract

Carcinoid tumors of the middle ear are very rare. Here we describe a 37-year-old man with multiple recurrent carcinoid tumor of the right middle ear. The CT demonstrated the recurrent mass that filled the tympanum and mastoid with osteolytic invasion, and the tumor was removed by surgery. The pathological findings showed the tumor cells, without necrosis and mitotic activity, had round, oval, or slightly irregular nuclei and finely-dispersed chromatin, arranged in cords, nests, and glandular structures. They were strongly positive for synaptophysin and CD56, but were negative for S-100 and chromogranin A. Ki-67 proliferation activity was low (<2%). With a review of the literature, the clinical, pathological characteristics and treatment modalities of this rare tumor are discussed.

Entities:  

Keywords:  Middle ear; carcinoid; immunohistochemistry; neuroendocrine carcinoma

Mesh:

Substances:

Year:  2014        PMID: 25400805      PMCID: PMC4230142     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  14 in total

1.  Immunohistochemical prognostic indicators of gastrointestinal carcinoid tumours.

Authors:  M Kawahara; M Kammori; H Kanauchi; C Noguchi; S Kuramoto; M Kaminishi; H Endo; K Takubo
Journal:  Eur J Surg Oncol       Date:  2002-03       Impact factor: 4.424

2.  Middle ear carcinoid with distant osseous metastasis.

Authors:  Christopher E Fundakowski; Jennifer R Chapman; Giovanna Thomas
Journal:  Laryngoscope       Date:  2012-07-09       Impact factor: 3.325

Review 3.  Carcinoid tumor of the middle ear: clinical features, recurrences, and metastases.

Authors:  Mitchell J Ramsey; Joseph B Nadol; Benjamin Z Pilch; Michael J McKenna
Journal:  Laryngoscope       Date:  2005-09       Impact factor: 3.325

4.  Ki-67 immunoreactivity in the differential diagnosis of pulmonary neuroendocrine neoplasms in specimens with extensive crush artifact.

Authors:  Deniz L Aslan; H Evin Gulbahce; Stefan E Pambuccian; J Carlos Manivel; Jose Jessurun
Journal:  Am J Clin Pathol       Date:  2005-06       Impact factor: 2.493

5.  Middle-ear carcinoid tumor with distant metastasis and fatal outcome.

Authors:  Ayman Gaafar; Cosme Ereño; José Ignacio López; Aitor Fernández de Larrinoa; Javier Grande; Julio Salazar; Jerusalem Yarnoz; Francisco José Bilbao
Journal:  Hematol Oncol Stem Cell Ther       Date:  2008 Jan-Mar

6.  Middle ear carcinoid: an indolent tumor with metastatic potential.

Authors:  E E Mooney; L G Dodd; T D Oury; J L Burchette; L J Layfield; R L Scher
Journal:  Head Neck       Date:  1999-01       Impact factor: 3.147

7.  Metastasizing middle ear carcinoid: an unusual case report, with focus on ultrastructural and immunohistochemical findings.

Authors:  Richard Salzman; Ivo Stárek; Vlastislava Tichá; Alena Skálová; Jiří Kučera
Journal:  Otol Neurotol       Date:  2012-10       Impact factor: 2.311

8.  A case of cervical metastases from temporal bone carcinoid.

Authors:  Raul Pellini; Marzia Ruggieri; Barbara Pichi; Renato Covello; Giovanni Danesi; Giuseppe Spriano
Journal:  Head Neck       Date:  2005-07       Impact factor: 3.147

9.  Adenoma versus carcinoid tumor of the middle ear: a study of 48 cases and review of the literature.

Authors:  Kevin R Torske; Lester D R Thompson
Journal:  Mod Pathol       Date:  2002-05       Impact factor: 7.842

10.  Surgical treatment by partial petrosectomy for a middle-ear carcinoid with progressive extension: a case report and review of the literature.

Authors:  Mitsuhiro Aoki; Keisuke Mizuta; Natsuko Ueda; Nansei Yamada; Yatsuji Ito; Hiroki Kato; Yoshinobu Hirose
Journal:  Int J Otolaryngol       Date:  2010-06-06
View more
  1 in total

Review 1.  Middle ear adenoma with uncommon presentation and literature review.

Authors:  Lin Wang; Nengtai Ouyang; Hai Xia Guo; Qing-Yu Liu
Journal:  BMJ Case Rep       Date:  2017-06-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.